Clicky

Microbix Biosystems Inc.(MBX)

Description: Microbix Biosystems Inc. is a life science company and manufacturer of viral and bacterial antigens and reagents for the diagnostics industry. The Company develops biological products and technologies. The Company operates in two segments: the development, manufacturing and distribution of cell-based products and technology, and the provision of facility, technical and production personnel for contract research and development. The Company's Virology Products (Virology) business manufactures and sells cell culture-based biological products. The Company's pipeline of technologies and products include Kinlytic, which is a thrombolytic drug with various applications, including the treatment of life-threatening blood clots, and LumiSort, which is a semen sexing technology for the livestock industries. It operates in three geographical areas, including North America, Europe and in other foreign countries. It owns and operates a Virology manufacturing facility at Mississauga, Ontario.


Keywords: Pipe Science Livestock Bacteria Pipeline Biological Products Manufacturing Facility Antigen Biological Blood Clots Mississauga Company's Pipeline Cell Based Products

Home Page: microbix.com

MBX Technical Analysis

265 Watline Avenue
Mississauga, ON L4Z 1P3
Canada
Phone: 905 361 8910


Officers

Name Title
Mr. Cameron L. Groome Pres, CEO & Director
Mr. James S. Currie Chief Financial Officer
Dr. Kenneth Hughes Ph.D. Chief Operating Officer
Dr. Mark Luscher Ph.D. Sr. VP of Scientific Affairs
Mr. Philip Casselli Sr. VP of Sales, Bus. Devel. & Marketing
Mr. Christopher B. Lobb Compliance Officer, Gen. Counsel & Sec.

Exchange: TO

Country: CA

Currency: Canadian Dollar (C$)

Forward PE: 9.5511
Trailing PE: 39
Price-to-Book MRQ: 2.4715
Price-to-Sales TTM: 2.8648
IPO Date:
Fiscal Year End: September
Full Time Employees: 0
Back to stocks